Pharming Group N.V. Restricted Cash And Cash Equivalents
Pharming Group N.V. (PHAR) had Restricted Cash And Cash Equivalents of $1.99 million as of 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:RestrictedCashAndCashEquivalents · last filed 2026-04-02
- 2020-12-31: Restricted Cash And Cash Equivalents 1.20M EUR.
EUR
| Period end | Restricted Cash And Cash Equivalents |
|---|---|
| 2020-12-31 | 1.20M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Restricted Cash And Cash Equivalents | Restricted Cash And Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | $1.99M 20-F · filed 2026-04-02 | |
| 2024-12-31 | $1.50M 20-F · filed 2026-04-02 | |
| 2023-12-31 | $1.53M 20-F · filed 2025-04-03 | |
| 2022-12-31 | $1.31M 20-F · filed 2024-04-04 | $1.30M 20-F · filed 2023-04-05 |
| 2021-12-31 | $1.00M 20-F · filed 2023-04-05 | |
| 2020-12-31 | $1.50M 20-F · filed 2022-04-06 |